Role of MAPKs in development and differentiation: lessons from knockout mice

Biochimie

Volumn 88, Issue 9, 2006, Pages 1091-1098

  Aouadi, M ^a   Binetruy, B ^a   Caron, L ^a   Le Marchand Brustel, Y ^a   Bost, F ^a  

^a INSERM   (France)

Author keywords

Differentiation; ERK; JNK; Mitogen activated protein kinase; Mouse development; p38MAPK

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE;

CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME SUBSTRATE; IN VITRO SELECTION; KNOCKOUT MOUSE; NONHUMAN; PHENOTYPE; REVIEW; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; ANIMAL; GENETICS; GROWTH, DEVELOPMENT AND AGING; MOUSE; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 7; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION;

EID: 33748781446     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2006.06.003     Document Type: Review

References (66)

1. Kyriakis J.M., and Avruch J. pp54 microtubule-associated protein 2 kinase. A novel serine/threonine protein kinase regulated by phosphorylation and stimulated by poly-l-lysine. J. Biol. Chem. 265 (1990) 17355-17363
2. Chen Z., Gibson T.B., Robinson F., Silvestro L., Pearson G., Xu B., Wright A., Vanderbilt C., and Cobb M.H. MAP kinases. Chem. Rev. 101 (2001) 2449-2476
3. Pearson G., Robinson F., Beers Gibson T., Xu B.E., Karandikar M., Berman K., and Cobb M.H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22 (2001) 153-183
4. Kolch W., and Coordinating E.R.K. MAPK signalling through scaffolds and inhibitors. Nat. Rev. Mol. Cell Biol. 6 (2005) 827-837
5. Yoshioka K. Scaffold proteins in mammalian MAP kinase cascades. J. Biochem. (Tokyo) 135 (2004) 657-661
6. Boulton T.G., and Cobb M.H. Identification of multiple extracellular signal-regulated kinases (ERKs) with antipeptide antibodies. Cell Regul. 2 (1991) 357-371
7. Boulton T.G., Nye S.H., Robbins D.J., Ip N.Y., Radziejewska E., Morgenbesser S.D., DePinho R.A., Panayotatos N., Cobb M.H., and Yancopoulos G.D. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65 (1991) 663-675
8. Lewis T.S., Shapiro P.S., and Ahn N.G. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74 (1998) 49-139
9. Chong H., Vikis H.G., and Guan K.L. Mechanisms of regulating the Raf kinase family. Cell. Signal. 15 (2003) 463-469
10. Frodin M., and Gammeltoft S. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol. Cell. Endocrinol. 151 (1999) 65-77
11. Pages G., Guerin S., Grall D., Bonino F., Smith A., Anjuere F., Auberger P., and Pouyssegur J. Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science 286 (1999) 1374-1377
12. Nekrasova T., Shive C., Gao Y., Kawamura K., Guardia R., Landreth G., and Forsthuber T.G. ERK1-deficient mice show normal T cell effector function and are highly susceptible to experimental autoimmune encephalomyelitis. J. Immunol. 175 (2005) 2374-2380
13. Mazzucchelli C., Vantaggiato C., Ciamei A., Fasano S., Pakhotin P., Krezel W., Welzl H., Wolfer D.P., Pages G., Valverde O., Marowsky A., Porrazzo A., Orban P.C., Maldonado R., Ehrengruber M.U., Cestari V., Lipp H.P., Chapman P.F., Pouyssegur J., and Brambilla R. Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory. Neuron 34 (2002) 807-820
14. Selcher J.C., Nekrasova T., Paylor R., Landreth G.E., and Sweatt J.D. Mice lacking the ERK1 isoform of MAP kinase are unimpaired in emotional learning. Learn. Mem. 8 (2001) 11-19
15. Bost F., Caron L., Marchetti I., Dani C., Le Marchand-Brustel Y., and Binetruy B. Retinoic acid activation of the ERK pathway is required for embryonic stem cell commitment into the adipocyte lineage. Biochem. J. 361 (2002) 621-627
16. Bost F., Aouadi M., Caron L., Even P., Belmonte N., Prot M., Dani C., Hofman P., Pages G., Pouyssegur J., Le Marchand-Brustel Y., and Binetruy B. The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes 54 (2005) 402-411
17. Saba-El-Leil M.K., Vella F.D., Vernay B., Voisin L., Chen L., Labrecque N., Ang S.L., and Meloche S. An essential function of the mitogen-activated protein kinase Erk2 in mouse trophoblast development. EMBO Rep. 4 (2003) 964-968
18. Hatano N., Mori Y., Oh-hora M., Kosugi A., Fujikawa T., Nakai N., Niwa H., Miyazaki J., Hamaoka T., and Ogata M. Essential role for ERK2 mitogen-activated protein kinase in placental development. Genes Cells 8 (2003) 847-856
19. Yao Y., Li W., Wu J., Germann U.A., Su M.S., Kuida K., and Boucher D.M. Extracellular signal-regulated kinase 2 is necessary for mesoderm differentiation. Proc. Natl. Acad. Sci. USA 100 (2003) 12759-12764
20. Fischer A.M., Katayama C.D., Pages G., Pouyssegur J., and Hedrick S.M. The role of erk1 and erk2 in multiple stages of T cell development. Immunity 23 (2005) 431-443
21. Derijard B., Hibi M., Wu I.H., Barrett T., Su B., Deng T., Karin M., and Davis R.J. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76 (1994) 1025-1037
22. Kyriakis J.M., Banerjee P., Nikolakaki E., Dai T., Rubie E.A., Ahmad M.F., Avruch J., and Woodgett J.R. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369 (1994) 156-160
23. Kyriakis J.M., and Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81 (2001) 807-869
24. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 103 (2000) 239-252
25. Bost F., McKay R., Dean N., and Mercola D. The JUN kinase/stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells. J. Biol. Chem. 272 (1997) 33422-33429
26. Dong C., Yang D.D., Wysk M., Whitmarsh A.J., Davis R.J., and Flavell R.A. Defective T cell differentiation in the absence of Jnk1. Science 282 (1998) 2092-2095
27. Dong C., Yang D.D., Tournier C., Whitmarsh A.J., Xu J., Davis R.J., and Flavell R.A. JNK is required for effector T-cell function but not for T-cell activation. Nature 405 (2000) 91-94
28. Hirosumi J., Tuncman G., Chang L., Gorgun C.Z., Uysal K.T., Maeda K., Karin M., and Hotamisligil G.S. A central role for JNK in obesity and insulin resistance. Nature 420 (2002) 333-336
29. Schattenberg J.M., Singh R., Wang Y., Lefkowitch J.H., Rigoli R.M., Scherer P.E., and Czaja M.J. JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Hepatology 43 (2006) 163-172
30. Sabapathy K., Jochum W., Hochedlinger K., Chang L., Karin M., and Wagner E.F. Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech. Dev. 89 (1999) 115-124
31. Yang D.D., Conze D., Whitmarsh A.J., Barrett T., Davis R.J., Rincon M., and Flavell R.A. Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. Immunity 9 (1998) 575-585
32. Jaeschke A., Rincon M., Doran B., Reilly J., Neuberg D., Greiner D.L., Shultz L.D., Rossini A.A., Flavell R.A., and Davis R.J. Disruption of the Jnk2 (Mapk9) gene reduces destructive insulitis and diabetes in a mouse model of type I diabetes. Proc. Natl. Acad. Sci. USA 102 (2005) 6931-6935 (Epub 2005)
33. Yang D.D., Kuan C.Y., Whitmarsh A.J., Rincon M., Zheng T.S., Davis R.J., Rakic P., and Flavell R.A. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389 (1997) 865-870
34. Kuan C.Y., Yang D.D., Samanta Roy D.R., Davis R.J., Rakic P., and Flavell R.A. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22 (1999) 667-676
35. Tournier C., Hess P., Yang D.D., Xu J., Turner T.K., Nimnual A., Bar-Sagi D., Jones S.N., Flavell R.A., and Davis R.J. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288 (2000) 870-874
36. Han J., Lee J.D., Bibbs L., and Ulevitch R.J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265 (1994) 808-811
37. Han J., Lee J.D., Tobias P.S., and Ulevitch R.J. Endotoxin induces rapid protein tyrosine phosphorylation in 70Z/3 cells expressing CD14. J. Biol. Chem. 268 (1993) 25009-25014
38. Jiang Y., Chen C., Li Z., Guo W., Gegner J.A., Lin S., and Han J. Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta). J. Biol. Chem. 271 (1996) 17920-17926
39. Lechner C., Zahalka M.A., Giot J.F., Moller N.P., and Ullrich A. ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation. Proc. Natl. Acad. Sci. USA 93 (1996) 4355-4359
40. Li Z., Jiang Y., Ulevitch R.J., and Han J. The primary structure of p38 gamma: a new member of p38 group of MAP kinases. Biochem. Biophys. Res. Commun. 228 (1996) 334-340
41. Jiang Y., Gram H., Zhao M., New L., Gu J., Feng L., Di Padova F., Ulevitch R.J., and Han J. Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38delta. J. Biol. Chem. 272 (1997) 30122-30128
42. Kumar S., McDonnell P.C., Gum R.J., Hand A.T., Lee J.C., and Young P.R. Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem. Biophys. Res. Commun. 235 (1997) 533-538
43. Enslen H., Raingeaud J., and Davis R.J. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J. Biol. Chem. 273 (1998) 1741-1748
44. Hanks S.K., and Hunter T. Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J. 9 (1995) 576-596
45. Zarubin T., and Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 15 (2005) 11-18
46. Tamura K., Sudo T., Senftleben U., Dadak A.M., Johnson R., and Karin M. Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis. Cell 102 (2000) 221-231
47. Mudgett J.S., Ding J., Guh-Siesel L., Chartrain N.A., Yang L., Gopal S., and Shen M.M. Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis. Proc. Natl. Acad. Sci. USA 97 (2000) 10454-10459
48. Allen M., Svensson L., Roach M., Hambor J., McNeish J., and Gabel C.A. Deficiency of the stress kinase p38alpha results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells. J. Exp. Med. 191 (2000) 859-870
49. Adams R.H., Porras A., Alonso G., Jones M., Vintersten K., Panelli S., Valladares A., Perez L., Klein R., and Nebreda A.R. Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol. Cell 6 (2000) 109-116
50. de Angelis L., Zhao J., Andreucci J.J., Olson E.N., Cossu G., and McDermott J.C. Regulation of vertebrate myotome development by the p38 MAP kinase-MEF2 signaling pathway. Dev. Biol. 283 (2005) 171-179
51. Paliga A.J., Natale D.R., and Watson A.J. p38 mitogen-activated protein kinase (MAPK) first regulates filamentous actin at the 8-16-cell stage during preimplantation development. Biol. Cell. 97 (2005) 629-640
52. Aouadi M., Bost F., Caron L., Laurent K., Le Marchand Brustel Y., and Binetruy B. P38MAPK activity commits embryonic stem cells to either neurogenesis or cardiomyogenesis. Stem Cells 24 (2006) 1399-1406
53. Aouadi M., Laurent K., Prot M., Le Marchand-Brustel Y., Binetruy B., and Bost F. Inhibition of p38MAPK increases adipogenesis from embryonic to adult stages. Diabetes 55 (2006) 281-289
54. Beardmore V.A., Hinton H.J., Eftychi C., Apostolaki M., Armaka M., Darragh J., McIlrath J., Carr J.M., Armit L.J., Clacher C., Malone L., Kollias G., and Arthur J.S. Generation and characterization of p38beta (MAPK11) gene-targeted mice. Mol. Cell. Biol. 25 (2005) 10454-10464
55. Sabio G., Arthur J.S., Kuma Y., Peggie M., Carr J., Murray-Tait V., Centeno F., Goedert M., Morrice N.A., and Cuenda A. p38gamma regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP. EMBO J. 24 (2005) 1134-1145
56. Kato Y., Kravchenko V.V., Tapping R.I., Han J., Ulevitch R.J., and Lee J.D. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J. 16 (1997) 7054-7066
57. Kato Y., Tapping R.I., Huang S., Watson M.H., Ulevitch R.J., and Lee J.D. Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor. Nature 395 (1998) 713-716
58. Chao T.H., Hayashi M., Tapping R.I., Kato Y., and Lee J.D. MEKK3 directly regulates MEK5 activity as part of the big mitogen-activated protein kinase 1 (BMK1) signaling pathway. J. Biol. Chem. 274 (1999) 36035-36038
59. Dinev D., Jordan B.W., Neufeld B., Lee J.D., Lindemann D., Rapp U.R., and Ludwig S. Extracellular signal regulated kinase 5 (ERK5) is required for the differentiation of muscle cells. EMBO Rep 2 (2001) 829-834
60. Liu L., Cavanaugh J.E., Wang Y., Sakagami H., Mao Z., and Xia Z. ERK5 activation of MEF2-mediated gene expression plays a critical role in BDNF-promoted survival of developing but not mature cortical neurons. Proc. Natl. Acad. Sci. USA 100 (2003) 8532-8537
61. Hayashi M., Kim S.W., Imanaka-Yoshida K., Yoshida T., Abel E.D., Eliceiri B., Yang Y., Ulevitch R.J., and Lee J.D. Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure. J. Clin. Invest. 113 (2004) 1138-1148
62. Hayashi M., and Lee J.D. Role of the BMK1/ERK5 signaling pathway: lessons from knockout mice. J. Mol. Med. 82 (2004) 800-808 (Epub 2004)
63. Regan C.P., Li W., Boucher D.M., Spatz S., Su M.S., and Kuida K. Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defects. Proc. Natl. Acad. Sci. USA 99 (2002) 9248-9253
64. Sohn S.J., Sarvis B.K., Cado D., and Winoto A. ERK5 MAPK regulates embryonic angiogenesis and acts as a hypoxia-sensitive repressor of vascular endothelial growth factor expression. J. Biol. Chem. 277 (2002) 43344-43351
65. Parasrampuria D.A., de Boer P., Desai-Krieger D., Chow A.T., and Jones C.R. Single-dose pharmacokinetics and pharmacodynamics of RWJ 67657, a specific p38 mitogen-activated protein kinase inhibitor: a first-in-human study. J. Clin. Pharmacol. 43 (2003) 406-413
66. Behr T.M., Berova M., Doe C.P., Ju H., Angermann C.E., Boehm J., and Willette R.N. p38 mitogen-activated protein kinase inhibitors for the treatment of chronic cardiovascular disease. Curr. Opin. Investig. Drugs 4 (2003) 1059-1064